Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
about
Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantsA proton NMR relaxation study of water dynamics in bovine serum albumin nanoparticles.Nanotechnology-based strategies for treatment of ocular disease.Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functionsPoly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study.Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug deliveryBrimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.Nanosuspensions: a promising drug delivery strategy.Cationic vectors in ocular drug delivery.Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers.Ocular drug delivery: nanomedicine applications.Nanoparticles in modern medicine: state of the art and future challenges.Topical ocular delivery of NSAIDs.Recent perspectives in ocular drug delivery.Toxicity of nanomaterials to the eye.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.Recent advances in ocular drug delivery.Novel strategies for anterior segment ocular drug delivery.Impacts of nanomedicines in ocular pharmacotherapyBreakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems.Colloidal drug delivery system: amplify the ocular delivery.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Uptake of Eudragit Retard L (Eudragit® RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats.Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis.Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.Ocular drug delivery: a clue from nanotechnology.Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarateComposite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate.Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-Efavirenz.Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experimentsPreparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromeneIncorporation of obidoxime into human serum albumin nanoparticles: optimisation of preparation parameters for the development of a stable formulation.Adsorption of obidoxime onto human serum albumin nanoparticles: drug loading, particle size and drug release.Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
P2860
Q28478420-D7865474-C37B-4667-AED7-68D5F7C234B4Q33519926-2450B834-78E2-442F-A55D-C19BB42F1317Q33681543-6B13A2DF-4137-47E2-AE7F-8570888CF98EQ34198276-AD6282E7-C357-4AE6-8F7D-1D8A80D402E8Q34707455-FFB10AEF-A371-4DBB-8A83-EDD478474F87Q35043797-7065B99F-8E98-4B6D-97FD-E80E2A13D10EQ35577210-5C3D88F8-F7D0-4CF6-A6C8-B8B6E8FD292BQ35826447-0DCC9839-ED17-4DD5-97FB-87B61B5CCA9BQ35994783-639BDB89-DB64-43A8-95AC-DC3963A0D233Q36244041-920D442E-AFE2-4058-8F41-CF48344DB536Q36918036-EE059CD1-F856-4A02-8A59-57FE08B35159Q36920457-148D5FE8-8D87-4C21-980F-F1523BA1928DQ37147923-61EA0338-6EAA-4267-9CDB-7CC3E6A44462Q37256549-070165E1-9C90-4A5C-A63F-29A85EBDA107Q37676123-116526C8-05D6-4C81-A6E7-FA9FD93A5198Q37769529-04E95698-1776-4021-A47C-F7A2E07707A6Q37776418-E9480EFB-0441-4B8F-9329-E98FA8B2EF7AQ38059884-644900C1-D728-4459-911B-122BDBE491B2Q38065184-CBE40F58-7689-485A-B0D8-E04A0ACD4490Q38107200-B41E2C8D-81AB-43A7-89B1-882CA4DFAE26Q38168361-9DD50060-A877-49F6-93E4-2FF9DE92F9DCQ38207118-C6F54343-A155-4EAA-BC68-FB4E060055A8Q38217270-158C1912-0D48-4EB4-A0FB-6A2E23A37827Q38227621-81CEEC15-6D5D-4DAE-A3C9-F53CC7172021Q38648168-6DBD3F59-DFDC-4D50-A36E-3DD9A5561FD3Q39020781-840BA80B-8CE4-4408-8FF2-B55BB19BA5AAQ40568609-808EC0C7-0364-47C8-9108-C7C3F1BF3719Q41116182-49993E19-6BB2-4AD8-ABB5-F8E72F533FD2Q41123414-C09353C6-28B6-4CEF-A0C7-CC690620A82AQ41568973-53E801B3-9587-43E5-8DB1-01C92BC44B1FQ42110933-9902EB3D-FCDF-4211-8D1F-C6D4F585F51AQ42125272-849EC2A5-3C72-4112-9FD9-04B064F683D0Q42131745-1324714C-E7A5-4273-98A2-850AB96D87A7Q42199787-4B30D9ED-B2F6-40BA-96A3-490639996A13Q42563685-6EC2A368-9993-4D5E-B706-6B5E1CAF685FQ42564191-916EDD25-1DBD-4FFB-AB4F-72F1EA67BA6AQ42869517-02E91EDB-DEAE-4C46-8BA4-058A591664DAQ43137250-4FCEABF7-7F58-490A-8C14-17C84A748238Q43259069-85CA566C-6D7D-4615-8748-538AE94A53F2Q44047035-5B101A68-AD99-4F1B-99B8-BAC01A3AC229
P2860
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@en
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@nl
type
label
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@en
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@nl
prefLabel
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@en
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@nl
P2093
P1433
P1476
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
@en
P2093
Spedalieri G
P304
P356
10.1016/S0142-9612(02)00080-7
P577
2002-08-01T00:00:00Z